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Introduction: There is increasing evidence to suggest that bone marrow lesions (BMLs) play a key role in the
pathogenesis of osteoarthritis (OA). However, there is a lack of long term data. The aim of this study was to
describe the natural history of knee BMLs, their association with knee pain and examine predictors of BML change
over eight years.
Methods: A total of 198 subjects (109 adult offspring of subjects who had a knee replacement and 89 community-based
controls) were studied. Knee pain and BML size were assessed at two and ten year visits.
Results: At the two year visit, 64% of participants (n = 127) had 229 BMLs (34% patella, 26% femoral and 40% tibial). Over
eight years, 24% (55/229) increased in size, 55% (125/229) remained stable and 21% (49/229) decreased in size or resolved
completely. Of the participants without BMLs at baseline, 52% (37/71) developed incident BMLs.
After adjusting for confounders, eight year change in total BML size was associated with change in knee pain in offspring
(β = 2.50, 95% confidence interval (CI) 0.96 to 4.05) but not controls. This association was stronger in males. Incident BMLs
were associated with increase in pain (β = 3.60, 95% CI 1.14 to 6.05). Body mass index (BMI) and strenuous activity (but
not radiographic osteoarthritis or smoking) were associated with an increase in BML size.
Conclusion: In this midlife cohort, the proportion of BMLs increasing in size was similar to those decreasing in size with
the majority remaining stable. Change in BMLs was predicted by BMI and strenuous activity. An increase in BML size or a
new BML resulted in an increase in pain especially in males and those with a family history of OA.Introduction
Osteoarthritis (OA) is the most common joint disorder
worldwide, and the knee is the most common joint af-
fected [1,2]. Bone marrow lesions (BMLs) play a key role
in the pathogenesis of knee OA – they are associated
with OA symptoms such as pain and function, and pre-
dict cartilage loss and joint replacement surgery [3-6]. In
a recent Delphi exercise that aimed to establish a defin-
ition for OA on magnetic resonance imaging (MRI),
BMLs were included as a key component of the diagnos-
tic criteria [7].* Correspondence: ycfoong@utas.edu.au
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unless otherwise stated.The current literature on the natural history of BMLs
is conflicting, with significant variation depending on
the study population. A study in a healthy population
has shown that incident BMLs developed in 14% of indi-
viduals over 2 years, and that knee pain was more likely
to develop in these participants [8]. The same study
showed that nearly one-half of the BMLs present at
baseline completely resolved, while another study of
middle-aged healthy women over 2 years found similar
results [9]. Studies in symptomatic OA populations gen-
erally show a lower percentage of BMLs resolving, with
one study reporting that less than 1% of patients showed
a BML decrease over 30 months [10]. Other studies have
quoted higher figures, with 10% of BMLs resolving over
2 years in a study by Kornaat and colleagues [11]. Our
group has previously reported that rates of incident
BMLs were low (7%), with about one-quarter of BMLsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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in a population-based cohort of older adults with and
without OA [3]. The reasons behind these variations are
unclear; however, it is worth noting that no study has
looked at the natural history of BMLs beyond 3 years.
Pain is a key criterion for a clinical diagnosis of OA. A
number of studies have reported an association between
BMLs and pain across a range of demographics and activ-
ities [12-16]. Furthermore, longitudinal studies have
shown that increases in BML size and incident BMLs are
both associated with increasing knee pain over 2 to 3 years
[17,18]. However, some studies have shown no association
between BMLs and pain longitudinally [11,19] or cross-
sectionally [20].
Given the role of BMLs in OA, there has been inter-
est in the risk factors that lead to an increased risk of
developing BMLs. There is significant overlap with the
major risk factors for OA, and age and weight have
been shown to be some of the strongest risk factors for
BMLs [21,22]. Physical activity, particularly doing over
10,000 steps per day, may aggravate existing BMLs [23].
Recently, vascular risk factors have also been implicated
due to their effects on blood flow in the small vessels
of subchondral bone [24]. Smoking, increased serum
glucose levels, serum cholesterol and triglyceride, fatty
acid intake, carbohydrate intake and changes in retinal
microvasculature have all been associated with BMLs
[25-29]. There is also a significant genetic component [30].
The conflicting data on natural history and clinical sig-
nificance may be attributable to the differing method-
ology in many of these studies. These include differences
in imaging protocols, sample size, age, sites measured,
and severity of OA in the study sample. Importantly, few
studies have followed the progression of BMLs beyond
3 years. The aims of this study were to describe the nat-
ural history of BMLs over 8 years, to examine the rela-
tionship between change in BML size and change in




This study was conducted as part of the Offspring study,
which is an ongoing population-based study. The Off-
spring study began in southern Tasmania (primarily in
the capital city of Hobart) in June 2000. One-half of the
participants were the adult offspring of patients who had
a knee replacement performed for idiopathic knee OA at
any Hobart hospital from 1996 to 2000 [31]. The diagno-
sis was confirmed by reference to the medical records of
the orthopedic surgeon and the original radiograph
when possible. Controls were age and sex matched and
were randomly selected from the population. Partici-
pants were excluded if they had a contraindication toMRI (including metal sutures, presence of shrapnel, iron
filing in eye, or claustrophobia). This study includes data
from the second and third visits at approximately 2 and
10 years respectively, because T2-weighted MRI scans
were not performed at baseline.
The Southern Tasmanian Health and Medical Human Re-
search Ethics Committee approved the protocol, and writ-
ten informed consent was obtained from all participants.
Anthropometrics
Weight was measured to the nearest 0.1 kg (with the
subject’s shoes, socks, and bulky clothing removed), with
a single pair of electronic scales (Delta Model 707; Seca,
Munich, Germany) that were calibrated using a known
weight at the beginning of each clinic session. Height
was measured to the nearest 0.1 cm (with shoes and
socks removed) using a stadiometer. Body mass index
(BMI) was calculated as weight (kg)/height (m2). Smok-
ing was assessed by questionnaire and categorized as
current smoker, past smoker or never smoked [32].
Physical activity was also assessed by a self-administered
questionnaire that assessed the amount of time spent in
light and strenuous physical activity on a five-point scale
[33]. Participants were asked about the number of days
during the last 14 days spent doing at least 20 minutes
of strenuous exercise (that is, bicycling, brisk walking,
jogging, aerobics, and so forth that was enough to raise
your pulse rate or cause you to breathe faster) and light
exercise (that is, walking, light housework, slow bicyc-
ling, and so forth that was not severe enough to cause a
pulse rate rising or breathing increase). The participants
then chose a score between 1 and 5, where score 1 rep-
resents no days, score 2 represents 1 or 2 days, score 3
represents 3 or 5 days, score 4 represents 6 or 8 days,
and score 5 represents 9 days or more of exercise.
Leg strength
Leg strength was measured by dynamometry at the
lower limb, involving both legs simultaneously. This pri-
marily involves the hip flexors and knee extensors. Each
measure was performed twice, with instructions given
prior to testing. The repeatability estimate (Cronbach’s
alpha) was 0.91. The device was calibrated by suspend-
ing known weights at regular intervals [34].
Knee pain
Knee pain was assessed by self-administered questionnaire
using the Western Ontario and McMaster Universities
Osteoarthritis Index at both visits [35]. Five categories of
pain (walking on flat surface, going up or down stairs, at
night, sitting or lying, and standing upright) were assessed
separately with a 10-point scale from 0 (no pain) to 9
(most severe pain). Each score was then summed to create
a total pain score (range 0 to 45).
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A standing anteroposterior semiflexed view of the right
knee (at 15° flexion) was performed in all participants at
baseline and 10 years. Radiographs were scored individu-
ally for osteophytes and joint space narrowing. Each of
the following four features was scored on a scale from 0
to 3 (0 = normal and 3 = severe): medial joint space nar-
rowing, lateral joint space narrowing, medial osteophytes
(femoral and tibial combined), and lateral osteophytes
(femoral and tibial combined). Each score was arrived at
by consensus with two readers simultaneously assessing
the radiograph with immediate reference to the Osteo-
arthritis Research Society International atlas [36]. A non-
zero score in either joint space narrowing or osteophytosis
was regarded as evidence of radiographic osteoarthritis
(ROA). Reproducibility was assessed in 50 radiographs,
2 weeks apart, and yielded an intraclass correlation co-
efficient of 0.99 for osteophytes and 0.98 for joint space
narrowing.
Magnetic resonance imaging
An MRI scan of the right knee was performed on a 1.5 T
whole-body magnetic resonance unit (Picker, Cleveland,
OH, USA) with the use of a commercial transmit–receive
extremity coil. Knees were imaged in the sagittal plane
and the following image sequences were used: visit two,
a T2-weighted fat saturation two-dimensional fast spin
echo (flip angle 90°; repetition time 3,067 ms; echo time
112 ms; field of view 16 cm; 256 × 256 matrix; slice
thickness of 4 mm with a between-slices gap of 0.5 to
1.0 mm); and visit three, a T2-weighted fat saturation
two-dimensional fast spin echo (flip angle 90°; repeti-
tion time 3,067 ms; echo time 112 ms; field of view
16 cm; 256 × 256 matrix; slice thickness of 2 mm with a
between-slices gap of 0.5 mm).
Visit one only involved T1 MRI scans, which were not
suitable for comparison of BMLs over time. Subchondral
BMLs were assessed using Osirix software (University of
Geneva, Geneva, Switzerland) and were defined as areas
of increased signal adjacent to the subcortical bone at
the medial tibial, medial femoral, lateral tibial, lateral
femoral, superior patella, and inferior patella sites as de-
scribed previously [3]. One trained observer scored the
BMLs by measuring the maximum area (cm2) of the le-
sion at both time points. The observer manually selected
the MRI slice with the greatest BML size. The BML
with the largest size was recorded if more than one le-
sion was present at the same site. MRIs at both time
points were read paired with the chronological order
known to the observer but blinded to clinical status.
Participants were given a BML score (cm2) for each of
the six sites (medial tibial, medial femoral, lateral tibial,
lateral femoral, superior patella, and inferior patella
sites) as well as a total BML score, which was the sumof the scores at each site. Change in BML size was then
calculated by subtracting the visit two BML size from
the visit three BML size. Intraobserver repeatability was
assessed in 40 subjects with at least a 2-week interval
between the readings. The intraclass correlation coeffi-
cient was 0.97.
To examine the natural history of BMLs, a significant
change in BML size was defined as any change above or
below the least significant criterion (LSC). The LSC takes
into account measurement error and the correlation be-
tween BML measurements at baseline and follow-up. The
formula is as follows, where σ is the standard error of the
mean and ρ is the serial correlation:




The LSC was calculated for each of the six sites in the
knee (11 mm2 for medial femoral, 17 mm2 for lateral
femoral, 16 mm2 for medial tibial, 14 mm2 for lateral
tibial, 15 mm2 for superior patellar, and 13 mm2 for in-
ferior patellar BMLs). This was then used to calculate
the number of BMLs increasing and decreasing in size,
where an increase in BML size was defined as any
change greater than the LSC, and vice versa for a de-
crease in BML.
Meniscal damage was assessed by a trained observer
on T1-weighted MRI scans as described previously [37].
Each meniscus is divided into three segments (anterior
horn, body and posterior horn) for the assessment of
both meniscal extrusions and tears.
Extrusion is defined as when meniscal tissue extends be-
yond the tibial margin, and complete extrusion is defined
as when the meniscus has no contact with the joint space.
For extrusions, each segment (anterior horn, body, and
posterior horn) of both medial and lateral menisci were
scored on a scale from 0 to 2 (0 = no extrusion, 1 = par-
tial meniscal extrusion, 2 = complete meniscal extrusion
with no contact with the joint space). Each meniscus can
have a maximum score of 6 and a total knee score of 12
for extrusions.
A maximum score of 6 can be given for tears (0 = no
damage, 1 = one of three meniscal areas involved (anter-
ior, middle, and posterior horns), 2 = two of three areas
involved, 3 = all three areas involved). This value was
then scored for both medial and lateral menisci, giving a
total score of 6.
These scores were summed to create a total meniscal
pathology score, which had a possible range from 0 to 18.
Statistical analysis
The characteristics of study participants were compared
using an independent-samples t test for continuous vari-
ables and a chi-squared test for categorical variables.
Linear regression was used to estimate the relationship
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was performed using total BML area (summed across all
six sites) as well BML area at each site specifically. Mul-
tivariable analyses were adjusted for age, sex, BMI, leg
strength, and the presence of ROA. Interactions between
BML change and sex, and between BML change and off-
spring–control status, were assessed from the coefficient
and its standard error of product terms was formed from
the covariates for the study factors involved. Linear re-
gression was also used to examine potential factors pre-
dicting a change in BML size. Univariable analysis was
performed with a range of lifestyle and demographic fac-
tors (BMI, physical activity, smoking status, ROA, and
offspring–control status) and those that were signifi-
cantly associated were included in the multivariable
model together with covariates for age and sex to adjust
for these factors.
Standard diagnostic checks of model adequacy were
performed on all final models. Residuals from all models
were normally distributed, or approximately so, without
evidence of heteroskedasticity.
Values of P <0.05 were considered statistically signifi-
cant. All statistical analysis was performed on Intercooled
Stata 12.0 for Windows (StataCorp LP).
Results
Participant characteristics
The participants in this study were 198 subjects with
complete MRI measures at the 2-year and 10-year visits
(52.7% of those studied at baseline). There were no sig-
nificant differences in sex, BMI, age, height, weight, fre-
quency of ROA, and pain at baseline between those lost
to follow up (n = 178) and the participants in our study
(n = 198) (data not shown). Table 1 presents the charac-
teristics of the study sample. BMLs were present in 64%
(127/198) of the sample at visit two, with an average
BML size of 0.63 cm2. Of note, those with BMLs re-
ported higher levels of pain at visit two and had a
greater change in BML size. There were no significant
differences in sex, age, BMI, offspring status, physical ac-
tivity levels, height, weight, or change in pain, although
those with BMLs tended to have a higher proportion
with ROA compared with those with no BMLs. The
mean (standard deviation) of physical activity in our co-
hort was 2.61 (1.33) for strenuous and 4.09 (1.11) for
light activity respectively (data not shown).
Natural history
The 127 participants with a BML had a total of 229
BMLs present at visit two (58 had a BML at one site, 45
had a BML at two sites, 17 had a BML at three sites, five
had a BML at four sites and two had a BML at five
sites). Figure 1 describes the natural history of these
BMLs. Roughly one-quarter of BMLs increased (n = 55)or decreased (n = 49) in size, whilst the remainder
remained unchanged in size (n = 125) based on a change
less than the LSC. Of those without BMLs at baseline
(n = 71), slightly over one-half developed one or more
incident BMLs (n = 37) over the 8 years. There was no
significant difference in natural history between off-
spring and controls (data not shown).
Pain
Table 2 presents associations between change in total
BML size and change in pain. Every 1 cm2 increase in
BML size resulted in a 1.53 (95% confidence interval =
0.37, 2.70) unit increase in pain score after adjustment
for age, sex, BMI, leg strength, and the presence of
ROA. Adjusting for baseline joint space narrowing,
osteophytes, meniscal extrusion, and meniscal tears did
not significantly affect our findings (<10% change in the
beta coefficient following further adjustment). A signifi-
cant offspring–control interaction was present (P = 0.08),
with change in BML size more strongly associated with
change in pain among offspring than controls. Further-
more, this association was stronger in males compared
with females among both the offspring group and the
whole sample.
Table 3 presents associations between site-specific
change in BML size and change in pain. Changes in
medial and lateral tibial BMLs were significantly associ-
ated with change in pain, with the association stronger
among offspring at the medial tibial site (P value for
interaction was <0.01). After adjustment for age, sex,
BMI, leg strength, and ROA, change in lateral tibial
BMLs and change in pain was no longer significantly as-
sociated. No significant association was found between
change in BML size and change in pain at other sites.
For those with no pain or BMLs present at baseline
(n = 42), the development of a BML was significantly as-
sociated with an increase in pain after adjustment for
age, sex, BMI, leg strength, and ROA in offspring and
controls combined with a change in pain score of 3.60
(95% confidence interval = 1.14 to 6.05) points per 1 cm2
change in BML size (not shown in Table 3).
Factors affecting bone marrow lesion change
Table 4 presents predictors of BML change. BMI and
strenuous activity were deleteriously associated with
change in BML size. These associations remained statis-
tically significant after adjusting for age and sex and each
other. Smoking status, the presence of ROA, light activ-
ity, offspring–control status, and leg strength was not as-
sociated with change in BML size.
Discussion
This population-based study of middle-aged adults has
investigated the natural history of BMLs over 8 years
Table 1 Participant characteristics
BML present (n = 127) BML not present (n = 71) P value
Females (%) 41% (51/127) 47% (33/71) 0.4
Age (years) 47.6 (6.5) 47.2 (6.0) 0.65
Offspring (%) 58% (74/127) 49% (35/71) 0.22
BMI (kg/m2) 28.0 (5.8) 27.0 (4.2) 0.24
Height (cm) 168.5 (9.2) 169.1 (8.9) 0.7
Weight (kg) 79.6 (18.1) 77.6 (15.1) 0.43
Leg strength (kg) 114.9 (47.4) 118.3 (44.3) 0.64
Active smokers (%) 17.3 15.5 0.77
Light activity (per unit change) 4.1 (0.09) 4.00 (0.15) 0.43
Strenuous activity (per unit change) 2.65 (0.12) 2.52 (0.15) 0.51
Radiographic osteoarthritis (%) 20% (26/127) 10 (7/71) 0.06
Pain score (0 to 29) 3.7 (5.9) 1.3 (3.1) <0.01
Change in pain score (−25 to 44) 2.5 (8.1) 2.2 (4.2) 0.84
Total BML area (0 to 4.10 cm2) 0.63 (0.80) – –
MF BML area (0 to 1.98 cm2) 0.37 (0.50) – –
LF BML area (0 to 2.54 cm2) 0.64 (0.75) – –
MT BML area (0 to 1.83 cm2) 0.33 (0.36) – –
LT BML area (0 to 1.99 cm2) 0.26 (0.31) – –
SP BML area (0 to 1.70 cm2) 0.38 (0.34) – –
IP BML area (0 to 1.06 cm2) 0.23 (0.27) – –
Change in BML area (−2.09 to 4.46 cm2) 0.61 (1.03) 0.28 (0.46) 0.01
Values were taken from visit two of the study, except for radiographic osteoarthritis that was taken from visit one. Change refers to the difference in values
between visit two and visit three. Values represent mean (standard deviation) unless percentages. Light and strenuous activity were rated on a five-point scale:
1 = no days, 2 = 1 or 2 days, 3 = 3 to 5 days, 4 = 6 to 8 days, and 5 = 9 days or more spent doing at least 20 minutes of the respective level of activity in the past
14 days. BMI, body mass index; BML, bone marrow lesion; IP, inferior patella; LF, lateral femoral; LT, lateral tibial; MF, medial femoral; MT, medial tibial; SP, superior
patella. Bold data indicate P <0.05.
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change in pain. Incident BMLs were common; roughly
one-half of those without BMLs at visit two developed
new BMLs by visit three. Of the BMLs present at visit
two, 55% remained stable while 24% increased and 21%
decreased in size. An increase in BML size or new BML
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Percentage(%)
Figure 1 Natural history of bone marrow lesions.for male offspring. BMI and strenuous activity independ-
ently predicted change in BML size.
This is the first study to report the natural history
of BMLs over an extended period of time. Many of
the previous studies have been conducted over a much
shorter timeframe. Davies-Tuck and colleagues reported a
much higher proportion of BMLs improving, with 46%
of BMLs resolving completely in a healthy, pain-free
population over 2 years [8]. In a symptomatic popula-
tion with ROA, less than 1% of BMLs resolved or re-
duced in size [10]. The conflicting data may be a
reflection of different study populations as well as dif-
ferent grading systems used for the assessment of
BMLs. In this study, patellar BMLs were also assessed,
which may explain the high percentage of participants
with BMLs compared with other studies that did not
assess patella BMLs [3,8,9]. A previous study by our
group in a population-based sample of older adults that
employed the same quantitative BML methodology
found very similar results to our current study where
approximately one-quarter of BMLs both increased and
decreased in size [3].
Table 2 Relationship between change in WOMAC and change in BML size
Univariable Multivariablea Femalesa Malesa
Total 1.74 (0.65, 2.84) 1.53 (0.37, 2.70) 0.63 (−0.93, 2.20) 2.53 (0.76, 4.30)
Offspring 2.68 (1.22, 4.13) 2.50 (0.96, 4.05) 2.25 (0.10, 4.41) 3.06 (0.88, 5.24)
Controls −0.05 (−1.72, 1.62) −0.39 (−2.23, 1.44) −0.77 (−3.51, 1.98) 1.44 (−1.25, 4.14)
Data presented as beta coefficient (95% confidence interval). Values are the change in WOMAC pain score per cm2 change in BML size. An interaction between
offspring–control status and change in BML size (P = 0.01) as well as sex and change in BML size (P = 0.08) on change in pain was present. BML, bone marrow
lesion; WOMAC, Western Ontario and McMasters Universities Arthritis Index. Bold data indicate P <0.05. aAdjusted for age, sex, body mass index, leg strength, and
radiographic osteoarthritis.
Foong et al. Arthritis Research & Therapy 2014, 16:R149 Page 6 of 9
http://arthritis-research.com/content/16/4/R149In our study, incident BMLs in subjects without BMLs
at visit two were also high, most probably due to the
period of follow-up. Other studies have reported much
lower figures, ranging from 9 to 14% in a healthy popu-
lation over 2 years [8,9] and 20% in a cohort with symp-
tomatic knee OA over 30 months [10]. Of clinical
importance, the development of an incident BML was
significantly associated with the development of pain in
those who were pain free at visit two. This association
has been corroborated by a prior study looking at
healthy populations [8] and a cohort consisting of sub-
jects with OA or at high risk of OA [17]. This observa-
tion further lends weight to the argument that BML
development may be a major contributor to incident
knee pain.
A 1 cm2 increase in BML size resulted in a 2.5 unit in-
crease in knee pain in those with a family history of OA,
whereas no association was seen in controls. Previous
findings from this cohort have shown that offspring with
a family history of knee replacement were more likely to
have a greater BMI, more knee pain, and less muscle
strength cross-sectionally compared with matched con-
trols [31]. However, there have been few studies examin-
ing the genetic factors influencing BMLs. Zhai and
colleagues reported that BMLs have a significant genetic
component in this cohort [30], but they did not investigateTable 3 Relationship between change in WOMAC and
site-specific change in BML size
Univariable Multivariablea
Medial tibial 2.96 (0.59, 5.34) 3.67 (0.89, 6.45)
Controls −1.39 (−4.18, 1.40) −3.38 (−7.15, 0.39)
Offspring 8.99 (5.30, 12.68) 8.98 (5.22, 12.73)
Lateral tibial 2.37 (0.08, 4.66) 1.98 (−0.36, 4.32)
Medial femoral 2.11 (−1.14,5.36) 1.63 (−1.64, 4.90)
Lateral femoral −0.09 (−2.41, 2.24) −0.69 (−3.11, 1.73)
Superior patella 0.74 (−2.73, 4.21) 0.61 (−2.85, 4.08)
Inferior patella 3.95 (−0.59, 8.50) 4.30 (−0.26, 8.86)
Data presented as beta coefficient (95% confidence interval). Values are the
change in WOMAC pain score per cm2 change in BML size. An interaction
between offspring and control status was present at the medial tibial site
(P <0.01). BML, bone marrow lesion; WOMAC, Western Ontario and McMasters
Universities Arthritis Index. Bold data indicate P <0.05. aAdjusted for age, sex,
body mass index, leg strength, and radiographic osteoarthritis.whether there was a genetic component to the role that
BMLs play in pain. BMLs are perhaps more likely to
cause pain in genetically susceptible individuals given
that genes can discriminate those with OA and pain
from those with OA without pain [38]. Alternatively,
BML pathology may be different in those with a family
history of OA and MRI is somewhat nonspecific with
regard to the underlying pathology.
The association between change in BMLs and change
in pain was also stronger in males compared with fe-
males. Few studies have reported on sex difference in
BMLs. Davies-Tuck and colleagues reported that sex
was not associated with the presence, development or
persistence of BMLs [8], whilst Dore and colleagues
found that males were more likely to have BMLs and
have a BML increase over time [3]. In our cohort, males
had significantly larger BMLs at both visit two and visit
three. When we adjusted our model for BML size at visit
two and visit three, however, the sex difference persisted,
suggesting that there may be a difference in the way
BMLs mediate pain between sexes.
When we examined site-specific BMLs and their asso-
ciation with pain, we found that tibial BMLs were associ-
ated with change in pain but not patellar or femoral
BMLs. In particular, medial tibial BMLs were strongly
associated with change in pain for offspring. To the bestTable 4 Predictors of change in bone marrow lesion size
Univariable Multivariablea
Body mass index (kg/m2) 0.03 (0.00, 0.05) 0.03 (0.01, 0.05)
Strenuous activity (per unit change) 0.13 (0.03, 0.22) 0.14 (0.04, 0.23)
Current smoker (yes/no) 0.04 (−0.13, 0.20) –
Ever smoker (yes/no) 0.06 (−0.20, 0.31) –
Radiographic osteoarthritis (yes/no) 0.28 (−0.06, 0.61) –
Light activity (per unit change) 0.02 (−0.10, 0.13) –
Offspring status (yes/no) 0.13 (−0.11, 0.38) –
Leg strength (kg) 0.00 (0.00, 0.00) –
Data presented as beta coefficient (95% confidence interval). Values are the
change in bone marrow lesion size (cm2) per unit change in covariates. All
factors are from visit two, except for radiographic osteoarthritis that was
collected at visit one. Strenuous and light activity were assessed on a five-point
scale: 1 = no days, 2 = 1 or 2 days, 3 = 3 to 5 days, 4 = 6 to 8 days and 5 = 9 days
or more. Bold data indicate P <0.05. aAdjusted for age, sex, body mass index,
and strenuous activity.
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associations between BMLs and pain. Studies have
shown that BMLs can lead to increased bone mineral
density locally [39,40] and greater cartilage loss at the
same site [5]. A local effect would thus be consistent
with the existing literature.
Higher BMI and strenuous activity were found to pre-
dict BML change. Obesity is a strong risk factor for
OA [41], and prior studies have also reported a cross-
sectional association between BMI and BML prevalence
and severity [42]. However, a 36-month follow-up found
no association between BML progression and BMI [42].
Similarly, high-intensity physical activity has been shown
to increase the risk of OA [43,44]. However these find-
ings need to be balanced against the strong evidence
demonstrating that physical activity improves symptoms
and physical function in OA [45]. A recent longitudinal
study by our group reported that physical activity mea-
sured by steps per day was deleteriously associated with
BML change [23]. Whilst we found a significant associ-
ation between strenuous physical activity and BML
change, we did not find an association between light
physical activity and BML change, suggesting intensity
of activity may be important. Therefore, whilst physical
activity may be good for symptoms, excessive physical
activity may be detrimental to knee structure. Random-
ized controlled trials evaluating the effect of physical ac-
tivity on a sensitive measure of knee structure, such as
MRI, are needed to gain a better understanding of this
relationship.
Our study has several potential limitations. Firstly,
slightly different MRI protocols were used at visit two
and visit three. Due to the long follow-up period, the
protocol at visit three had slightly different parameters –
namely a smaller slice thickness. This means that a
greater number of small BMLs might have been picked
up at visit three; the rate of incident BMLs over 8 years
may therefore not be as high as our study indicates.
There may also have been an overestimate of BML
change, which would mean that the true magnitude of
the association between BML change and change in pain
is stronger.
Secondly, due to the long follow-up period, a signifi-
cant proportion of our subjects were lost to follow-up.
However, there were no significant differences in pain
scores and demographics between those lost to follow-
up and participants in this study, suggesting this bias
was not systematic.
Thirdly, BML area was measured by taking the slice
with the greatest BML size at a particular site. This is a
surrogate measure of volume and may overestimate shal-
low, flat lesions. However, this method of BML measure-
ment has proven to be sensitive to change in a recent
clinical trial [46].Fourthly, the interslice gap was 0.5 to 1.0 mm, which
means that small BMLs might have been missed if they
lay completely within the interslice gap, which seems
unlikely.
Fifthly, we used a subjective measure of physical activ-
ity to assess the amount of light and strenuous activity
that participants undertook. We also did not differenti-
ate between different modes of physical activity such as
weight-bearing and nonweight-bearing exercise, and did
not specifically ask about strenuous incidental physical
activity (for example, occupational or household activ-
ity). It is also important to note that only current phys-
ical activity data were captured over a 14-day period as
opposed to a longitudinal measure of physical activity.
However, the significant correlation between strenuous
activity and BML change is consistent with pedometer-
derived physical activity.
Sixthly, we did not assess analgesia such as paracetamol
or nonsteroidal anti-inflammatory drugs or knee malalign-
ment, which could have been potential confounders.
Lastly, ROA was assessed at baseline and not at visit
two. This difference in timing may result in a slight
underestimate in the prevalence of ROA at visit two,
which may influence the borderline results.
Conclusion
In this midlife cohort, the proportion of BMLs increas-
ing in size was similar to those decreasing in size, with
the majority remaining stable. Change in BMLs can be
predicted by lifestyle factors, namely BMI and strenuous
activity. An increase in BML size or a new BML resulted
in an increase in pain especially in males and those with
a family history of OA.
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